Immune cell analysis reveals the amount of SARS-CoV-2 in blood is a strong predictor of mortality

CITF-funded researchers Drs. Daniel Kaufmann, Andrés Finzi and Nicolas Chomont from the Université de Montréal and the Université de Montréal hospital research centre (CRCHUM), along with their collaborators, found that the amount of viral mRNA  in the blood can help identify hospitalized patients who will suffer severe COVID-19, and even death.